Table 3.
Studies on the relationship between CYP2D6 genotype and neuroleptic-induced movement disorders.
| Study | Side-effect | Relationship with CYP2D6 genotype |
|---|---|---|
| Arthur et al.[72] | Tardive dyskinesia | No |
| Armstrong et al.[73] | Acute dystonia | No |
| Chronic movement disorders | No (non-sign tendency) | |
| Andreasson et al.[74] | Tardive dyskinesia | No (non-sign tendency) |
| Parkinsonism | No | |
| Akathisia | No | |
| Kapitany et al.[75] | Tardive dyskinesia | Yes |
| Ohmori et al.[76] | Tardive dyskinesia | No |
| Vandel et al.[77] | Extrapyramidal side- effects | Yes |
| Hamelin et al.[78] | Not defined | No |
| Scordo et al.[79] | Extrapyramidal side- effects | No |